Literature DB >> 671428

A controlled trial of the theory of acupuncture in musculoskeletal pain.

C M Godfrey, P Morgan.   

Abstract

We carried out a randomized trail compraing acupuncture done is theoretically correct [appropriate] and incorrect [inappropirate] locations for chronic musculoskeletal pains in various sites. Throughout the trial, neither the patient, nor the assessor, nor the acupuncturist, knew if the site of the acupuncture was appropriate to the patient's symptoms according to acupuncture theory. Although 60% had reduced pain after three treatments, there was no significant difference between the treatments. Our findings, while not disproving the value of acupuncture, do not support the theory that certain specific points must be needled to relieve specific areas of pain.

Entities:  

Mesh:

Year:  1978        PMID: 671428

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Electroacupuncture in the treatment of chronic lameness in horses and ponies: a controlled clinical trial.

Authors:  J E Steiss; N A White; J M Bowen
Journal:  Can J Vet Res       Date:  1989-04       Impact factor: 1.310

2.  Acupuncture: a useful treatment modality.

Authors:  L M Rapson
Journal:  Can Fam Physician       Date:  1984-01       Impact factor: 3.275

3.  Placebo controls for acupuncture studies.

Authors:  C Vincent; G Lewith
Journal:  J R Soc Med       Date:  1995-04       Impact factor: 5.344

Review 4.  How effective is acupuncture in the management of pain?

Authors:  G T Lewith
Journal:  J R Coll Gen Pract       Date:  1984-05

5.  Can we assess the effects of acupuncture?

Authors:  G T Lewith
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

Review 6.  Research on traditional Chinese acupuncture--science or myth: a review.

Authors:  S E Prance; A Dresser; C Wood; J Fleming; D Aldridge; P C Pietroni
Journal:  J R Soc Med       Date:  1988-10       Impact factor: 18.000

7.  Neurobiology of Acupuncture: Toward CAM.

Authors:  Sheng-Xing Ma
Journal:  Evid Based Complement Alternat Med       Date:  2004-06-01       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.